ASHP Advantage Podcasts

Potential Use of Platelet Function and Genetic Testing in Guiding Oral Antiplatelet Therapy in Acute Coronary Syndrome Summary: The content for this podcast was adapted from an interview with Julie Oestreich recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Oestreich is Assistant Professor in the Department of Pharmacy Practice in the College of Pharmacy at the University of Nebraska Medical Center (UNMC) in Omaha. Dr. Oestreich discusses some of the clinical challenges in oral antiplatelet therapy, especially as they relate to platelet function and genetic testing. Julie H. Oestreich, Pharm.D., Ph.D. Assistant Professor of Pharmacy Practice College of Pharmacy University of Nebraska Medical Center Omaha, Nebraska C.E. Credits: Not available for this activity.

Current Options for Managing Antiplatelet Therapy in Patients with Acute Coronary Syndrome. Summary: The content for this podcast was adapted from an interview with Toby Trujillo recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Trujillo is Associate Professor of Clinical Pharmacy at the University of Colorado Denver School of Pharmacy in Aurora, Colorado. He also serves as Clinical Specialist in cardiovascular pharmacotherapy and anticoagulation at University of Colorado Hospital. Dr. Trujillo discusses issues related to current options for managing antiplatelet therapy in patients with acute coronary syndrome. Toby C. Trujillo, Pharm.D., BCPS (AQ Cardiology) Associate Professor University of Colorado Denver School of Pharmacy Clinical Specialist – Cardiology/Anticoagulation University of Colorado Hospital Aurora, Colorado C.E. Credits: Not available for this activity.

Atrial Fibrillation: Focus on Stroke Prevention Summary: The content for this podcast was adapted from an interview with Ann Wittkowsky that was recorded on December 5th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Wittkowsky is Clinical Professor at the University of Washington School of Pharmacy, and Director of Anticoagulation Services at the University of Washington Medical Center in Seattle, Washington. Dr. Wittkowsky will discuss the Role of the Pharmacist in Identifying and Overcoming Barriers to Appropriate and Well-managed Antithrombotic Therapy. Ann K. Wittkowsky, Pharm.D., CACP, FASHP, FCCP Clinical Professor University of Washington School of Pharmacy Director, Anticoagulation Services University of Washington Medical Center Seattle, Washington C.E. Credits: Not available for this activity.

Atrial Fibrillation: Focus on Stroke Prevention Summary: The content for this podcast was adapted from an interview with James Kalus that was recorded on December 6th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Kalus is Senior Manager, Patient Care Services of the Department of Pharmacy Services at Henry Ford Hospital in Detroit, Michigan. Dr. Kalus will discuss Future Directions: Emerging Therapies for Stroke Prevention in Atrial Fibrillation. James S. Kalus, Pharm.D., BCPS (AQ-Cardiology) Senior Manager, Patient Care Services Department of Pharmacy Services Henry Ford Hospital Detroit, Michigan C.E. Credits: Not available for this activity.

Atrial Fibrillation: Focus on Stroke Prevention Summary: The content for this podcast was adapted from an interview with Cynthia Sanoski that was recorded on December 5th, 2010, during the 45th ASHP Midyear Clinical Meeting and Exhibition in Anaheim, California. Dr. Sanoski is Chair and Associate Professor of the Department of Pharmacy Practice at Jefferson School of Pharmacy, Thomas Jefferson University in Philadelphia, Pennsylvania. Dr. Sanoski will discuss Stroke Prevention in Atrial Fibrillation: Reviewing the Basics. Cynthia A. Sanoski, Pharm.D., FCCP, BCPS, Initiative Chair Chair and Associate Professor Department of Pharmacy Practice Jefferson School of Pharmacy Thomas Jefferson University Philadelphia, Pennsylvania C.E. Credits: Not available for this activity.

Clinical Considerations of Risk Evaluation and Mitigation Strategies in Health Care Systems: Design, Implementation, and Management Summary: The content for this podcast was adapted from an interview with JoAnn Stubbings recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Ms. Stubbings is Manager of Research and Public Policy in the Ambulatory Care Pharmacy Department at the University of Illinois (UIC) at Chicago College of Pharmacy and Clinical Associate Professor in the Department of Pharmacy Practice. She also serves as chair of the risk evaluation and mitigation strategies educational initiative coordinated by ASHP Advantage. Ms. Stubbings will discuss practical applications and opportunities presented by REMS. JoAnn Stubbings, MHCA, B.S. Pharm. Clinical Associate Professor Manager, Research and Public Policy University of Illinois at Chicago College of Pharmacy Chicago, Illinois C.E. Credits: Not available for this activity.

The Background, History and Current Status of Risk Evaluation and Mitigation Strategies. Summary: The content for this podcast was adapted from an interview with Stephen Goldman recorded in December 2010 during the 45th ASHP Midyear Clinical Meeting and Exhibition. Dr. Goldman is an independent consultant with extensive experience in academic and clinical medicine, public health, federal medical product safety regulations, and the pharmaceutical industry. Stephen A. Goldman, M.D., FAPM, DFAPA Former Medical Director, MedWatch,U.S. Food and Drug Administration Managing Member, Stephen A. Goldman Consulting Services, LLC Morris Plains, New Jersey C.E. Credits: Not available for this activity.

Highlighting One Patient’s Story: The Impact of VTE Michael P. Gulseth, Pharm.D., BCPS Part 1: Highlighting One Patient’s Story: The Impact of VTE Michael P. Gulseth, Pharm.D., BCPS Part 2: Development of a VTE Risk Assessment Model and Protocol Jordan C. Messler, M.D., FHM Overview Venous thromboembolism (deep vein thrombosis, pulmonary embolism, or both) remains a significant threat to patient safety. At least 100,000 deaths are attributable to venous thromboembolism (VTE) each year in the United States. VTE is primarily a problem of hospitalized and recently-hospitalized patients. Although the majority of medical and surgical inpatients have multiple risk factors for VTE, evidence shows that only 30% to 50% of patients receive adequate prophylaxis. Barriers to the use of prophylaxis include lack of familiarity with published clinical guidelines, underestimation of VTE risk, concern over risk of bleeding from anticoagulants, and difficulty achieving hospital-wide implementation of risk assessment procedures. To improve inpatient safety, regulatory and professional organizations have endorsed practice guidelines for VTE prophylaxis. Current guidelines from the American College of Chest Physicians recommend that hospitals develop a formal strategy to prevent thromboembolic complications and, more specifically, provide prophylaxis in patients with VTE risk factors. This activity will outline a multidisciplinary team approach to the implementation of effective VTE risk assessment and prevention strategies in hospitalized patients. Physician leadership of the multidisciplinary team is essential to integrate VTE risk assessment processes into routine patient care practices. A case study will be used to illustrate important concepts as well as provide active learning for participants. Continuing Education This activity was recorded on May 4, 2010. Continuing education credit for this podcast is available through November 30, 2011, for pharmacists, physicians, nurses, nurse practitioners, and case managers. To be eligible for continuing education credit, you must complete the post-test and post-activity evaluation online at the ASHP Advantage CE Testing Center. Complete information and continuing education accreditation statements are included in the audio podcast and are also found in the presentation handout (PDF), which is included with the podcast. This activity is planned and coordinated by ASHP Advantage and is supported by an educational grant from Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.

Highlighting One Patient’s Story: The Impact of VTE Michael P. Gulseth, Pharm.D., BCPS Part 1: Highlighting One Patient’s Story: The Impact of VTE Michael P. Gulseth, Pharm.D., BCPS Part 2: Development of a VTE Risk Assessment Model and Protocol Jordan C. Messler, M.D., FHM Overview Venous thromboembolism (deep vein thrombosis, pulmonary embolism, or both) remains a significant threat to patient safety. At least 100,000 deaths are attributable to venous thromboembolism (VTE) each year in the United States. VTE is primarily a problem of hospitalized and recently-hospitalized patients. Although the majority of medical and surgical inpatients have multiple risk factors for VTE, evidence shows that only 30% to 50% of patients receive adequate prophylaxis. Barriers to the use of prophylaxis include lack of familiarity with published clinical guidelines, underestimation of VTE risk, concern over risk of bleeding from anticoagulants, and difficulty achieving hospital-wide implementation of risk assessment procedures. To improve inpatient safety, regulatory and professional organizations have endorsed practice guidelines for VTE prophylaxis. Current guidelines from the American College of Chest Physicians recommend that hospitals develop a formal strategy to prevent thromboembolic complications and, more specifically, provide prophylaxis in patients with VTE risk factors. This activity will outline a multidisciplinary team approach to the implementation of effective VTE risk assessment and prevention strategies in hospitalized patients. Physician leadership of the multidisciplinary team is essential to integrate VTE risk assessment processes into routine patient care practices. A case study will be used to illustrate important concepts as well as provide active learning for participants. Continuing Education This activity was recorded on May 4, 2010. Continuing education credit for this podcast is available through November 30, 2011, for pharmacists, physicians, nurses, nurse practitioners, and case managers. To be eligible for continuing education credit, you must complete the post-test and post-activity evaluation online at the ASHP Advantage CE Testing Center. Complete information and continuing education accreditation statements are included in the audio podcast and are also found in the presentation handout (PDF), which is included with the podcast. This activity is planned and coordinated by ASHP Advantage and is supported by an educational grant from Ortho-McNeil, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.

During the week of March 2nd through the 8th in 2008, ASHP and the ASHP Research and Education Foundation marked National Patient Safety Awareness Week with a radio tour. The radio tour emphasized the pharmacists' role in medication safety. Dr. Scott T. Micek, a clinical pharmacist at Barnes-Jewish Hospital in St. Louis, was interviewed by 17 radio stations, including CNN Radio. The interviews were designed to educate consumers about the vital patient-care role pharmacists play in hospitals and health systems. This podcast includes the interview with WIBW in Topeka, Kansas. Permission to share this interview with the public was granted by the Kansas Information Network and James Doblin, who conducted the interview.) The Barnes-Jewish Hospital's team, which was led by Dr. Micek, received the 2007 Award for Excellence in Medication-Use Safety. The ASHP Foundation created the Award for Excellence in Medication-Use Safety in 2004. It is the only award program to honor a pharmacist-led, multidisciplinary team for its significant institution-wide system improvements relating to medication use. The $50,000 award recognizes on a national level pharmacy professionals who have assumed a leadership role in promoting safety in the medication-use process. The award is sponsored by the Cardinal Health Foundation.For more information, please visit www.ashpfoundation.org.

During the week of March 2nd through the 8th in 2008, ASHP and the ASHP Research and Education Foundation marked National Patient Safety Awareness Week with a radio tour. The radio tour emphasized the pharmacists' role in medication safety. Dr. Scott T. Micek, a clinical pharmacist at Barnes-Jewish Hospital in St. Louis, was interviewed by 17 radio stations, including CNN Radio. The interviews were designed to educate consumers about the vital patient-care role pharmacists play in hospitals and health systems. This podcast includes the interview with WIBW in Topeka, Kansas. Permission to share this interview with the public was granted by the Kansas Information Network and James Doblin, who conducted the interview.) The Barnes-Jewish Hospital's team, which was led by Dr. Micek, received the 2007 Award for Excellence in Medication-Use Safety. The ASHP Foundation created the Award for Excellence in Medication-Use Safety in 2004. It is the only award program to honor a pharmacist-led, multidisciplinary team for its significant institution-wide system improvements relating to medication use. The $50,000 award recognizes on a national level pharmacy professionals who have assumed a leadership role in promoting safety in the medication-use process. The award is sponsored by the Cardinal Health Foundation.For more information, please visit www.ashpfoundation.org.